| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |